Skip to main content
| News

Lyfegen collaborating with Johnson & Johnson

03.08.2021

The Basel-based startup Lyfegen has developed a platform for value-based healthcare. This should provide improved outcomes for patients and result in cost-savings. Lyfegen teamed up with Johnson & Johnson for the implementation.

Girisha Fernando, Frederico Braga, Michel Mohler and Nico Mros from Lyfegen HealthTech AG (img: Lyfegen)

The concept of value-based healthcare is rooted in the definition of patient outcome per franc spent. By aligning all processes with this approach, the aim is to improve patient outcomes and reduce healthcare costs at the same time. Founded in 2018, the Basel-based company Lyfegen has developed a platform that can be used to implement value-based healthcare processes. Lyfegen teamed up with the life sciences company Johnson & Johnson Switzerland and a “leading” Swiss hospital for the implementation process, which has now been brought to a close, further details of which can be found in a press release.

The patented Lyfegen platform automates the collection and analysis of all patient-related data. In this way, the aim is to achieve transparency with regard to the contract content, expenses and healthcare outcomes. Lyfegen describes the platform as a “blueprint” from which global hospitals, health insurance companies and life sciences providers all stand to benefit. “Covid-19 has shown us the urgent need for a more sustainable healthcare system”, comments Girisha Fernando, CEO of Lyfegen, in the press release. “With the implementation of value-based healthcare agreements on the Lyfegen platform, we are extremely proud to help Johnson & Johnson and hospitals to accelerate the transition to value-based healthcare and improve patient health outcomes at reduced cost”.

For Lyfegen, the agreed partnership represents a key “milestone”, the press release explains further. The Basel-based startup recently opened up a new investment round.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area achieves milestone with settling of LifeMine
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Basel Area achieves milestone with settling of LifeMine

Life sciences company LifeMine Therapeutics from the USA has established its European headquarters in the Basel Area. With this, Basel...

Read More
Space Pharmaceuticals establishes presence in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Space Pharmaceuticals establishes presence in Basel

Space Pharmaceuticals AG is strengthening the life sciences cluster in the Basel Area. At its research lab, the cheminformatics company...

Read More
Basel Area Business & Innovation, Innovation, Life Sciences / biotech

NextImmune to benefit from Venture Kick financing

The startup accelerator Venture Kick is supporting NextImmune with financing in the amount of 150,000 Swiss francs. The spin-off from...

Read More
Basel Area Business & Innovation, Innovation, Medtech, Switzerland Innovation Park

OECD impressed by the canton of Jura’s innovation system

The OECD has examined the innovation systems in place in rural areas of its member states, including the canton of...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest

ti&m opens branch in Basel

ti&m now has an office in Basel. With this action, the company specializing in digitization, security and innovation projects is...

Read More
What can artificial intelligence do for health?
Basel Area Business & Innovation, Digital Health, Innovation, Life Sciences / biotech, Medtech

What can artificial intelligence do for health?

Algorithms help diagnose and treat diseases, discover new drugs and personalize prevention. Thus, the potential of artificial intelligence has been...

Read More
1 2 3 56

Do you have a question? We'd like to hear from you.